Archive
Back to homepage
Kelantan hotels to carry out sanitisation to boost tourist confidence
KOTA BARU: The Kelantan state government will work with hotel operators in the state to carry out sanitisation of all hotels here so as to boost tourist confidence. Chairman of the Kelantan Unity, Culture, Heritage and Tourism Committee, Datuk Md Anizam
Read More
Unemployment issue to be discussed in parliament today
KUALA LUMPUR: The issue on unemployment is among topics to be discussed in the Dewan Rakyat sitting today. According to the Order Paper on the Parliament website, Datuk Seri Anwar Ibrahim (PH-Port Dickson) is scheduled to ask Minister of Human Resources
Read More
Section 17A of MACC Act can curb graft post-MCO
PUTRAJAYA: Section 17A of the MACC Act 2009, which came into force on June 1, is the perfect weapon to curtail corruption at a time when companies struggling to keep afloat may consider bribery to earn a quick profit. Malaysian Anti-Corruption
Read More
Meta-Analysis from Biosense Webster, Inc. Reveals Positive Effects of Real-Time Ultrasound Imaging During Cardiac Ablation to Treat Arrhythmias
TOKYO, July 20, 2020 /PRNewswire/ — Biosense Webster, Inc., part of the Johnson & Johnson Medical Devices Companies*, in collaboration with researchers at the Tokyo Medical and Dental University and CTI Clinical Trial Consulting published findings in the demonstrating
Read More
Hill+Knowlton Strategies Elevates Emily Yin to Head of Business Development in the Guangdong-Hong Kong-Macao Greater Bay Area
HONG KONG, July 20, 2020 /PRNewswire/ — Hill+Knowlton Strategies Greater China (“H+K”) recently announced its decision to elevate Emily Yin to Senior Vice President of Greater China and Head of Business Development in the Guangdong-Hong Kong-Macao Greater Bay Area. Emily will
Read More
Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization
SHANGHAI, July 20, 2020 /PRNewswire/ — Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and best-in-class therapies, today announced that it has successfully closed US$97 million in Series C financing. Antengene
Read More